Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05166187 · ClinicalTrials.gov registry record · NA
Best Practice Advisory to Initiate High-Intensity Statin Therapy in Patients With Peripheral Artery Disease
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT05166187 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 152 participants.
The verdict
NCT05166187, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
The purpose of this study is to understand how a Best Practice Advisory (BPA) for high-intensity statin therapy in patients with Peripheral Artery Disease impacts prescription rates.
Interventions
- OTHER Best Practice Advisory
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2022-04-20 |
| Est. Completion | 2023-11-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05166187
The ClinicalTrials.gov registry entry for NCT05166187 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Best Practice Advisory is the first listed.
NCT05166187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05166187 about?
NCT05166187 is a clinical study titled "Best Practice Advisory to Initiate High-Intensity Statin Therapy in Patients With Peripheral Artery Disease". The purpose of this study is to understand how a Best Practice Advisory (BPA) for high-intensity statin therapy in patients with Peripheral Artery Disease impacts prescription rates.
What is the current status of trial NCT05166187?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2022-04-20. Estimated completion is 2023-11-13.
What interventions are being tested in trial NCT05166187?
The interventions under investigation include: Best Practice Advisory (OTHER).
Who is sponsoring clinical trial NCT05166187?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.